Article
Evaluation of enzymatic mutation detectiontrade mark in hereditary nonpolyposis colorectal cancer.
Human mutation - 1 Jan 2000
Otway R, Tetlow N, Hornby J, Kohonen-Corish M
Abstract excerpt
In hereditary nonpolyposis colorectal cancer (HNPCC), the majority of reported mutations are dispersed throughout the 35 exons of the two principal susceptibility genes, MLH1 and MSH2, and because of this complexity, rapid mutation screening methods are required. The aim of this study was to evaluate the sensitivity of the Enzymatic Mutation Detection (EMD) assay in HNPCC using genomic DNA samples with known gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
